For More Than Two Decades, We’Ve Fueled Those With The Strength To Not Just Play The Game, But To Change It. And Cell-Tech Creactor Expands On This Tradition With An Incredibly Versatile Creatine Formula Designed For Maximum Results In Lean Muscle, Strength And Recovery!.
GO BIG OR GO HOME!
Build serious lean muscle with this ultimate concentrated creatine formula. Cell-Tech Creactor delivers 750mg of Creatine HCI and 750mg of Free-Acid Creatine per serving to help improve your muscle recovery between sets, amplify muscle size & performance, and get stronger every day. Each serving delivers more creatine directly to your muscles than the other guys, so you get more of what you want in every scoop.
CLINICALLY PROVEN FOR MAX POTENCY & EFFECTIVENESS
Specially formulated and science backed, every serving of Cell-Tech Creactor delivers the ideal 1:1 ratio of creatine hydrochloride (HCI) plus free-acid creatine, the purest form available— so you can avoid bloating and never have to load or cycle it.
750MG CREATINE HCI
Creatine HCl is a cutting-edge, potent form of creatine with unique solubility properties.
750MG FREE-ACID CREATINE
The purest form of creatine on the market. Free-acid creatine delivers the most usable creatine on a gram for gram basis. More than creatine monohydrate or any other type of creatine available.
HOW AND WHEN TO TAKE
Mix 1 scoop with 6 to 8 oz. of water or mix 2 scoops with 12 to 16 oz. of water. Take up to 2 times per day. On workout days, take 1 serving 30 to 45 minutes before training. As with all creatine products, maintain an adequate state of hydration during use.
INCREASE STRENGTH & GAIN MORE MUSCLE
The amount of creatine found in just two super-concentrated scoop of Cell-Tech Creactor is scientifically proven to increase muscle strength, size, and performance.
HARNESS THE ENERGY OF AMPLIFIED ATP SYNTHESIS
This formula rapidly enhances your muscle cells’ ability to regenerate adenosine triphosphate (ATP) – their primary source of anaerobic energy – so you can recover faster between sets.
